NK cell therapy: targeting disease relapse after hematopoietic stem cell transplantation (Q26863559)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22329587%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

NK cell therapy: targeting disease relapse after hematopoietic stem cell transplantation (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22329587%20AND%20SRC:MED&resulttype=core&format=json

stem cell transplantation

22 January 2020

main subject

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22329587%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22329587%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Richard E Champlin

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22329587%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Stefan O Ciurea

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22329587%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

language of work or name

1 reference

13 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22329587%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22329587%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22329587%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22329587%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

305-313

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22329587%20AND%20SRC:MED&resulttype=core&format=json

Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells

22 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Isotypic variation of novel immunoglobulin-like transcript/killer cell inhibitory receptor loci in the leukocyte receptor complex

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

In search of the 'missing self': MHC molecules and NK cell recognition

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Biology of natural killer cells

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Oncogenic stress sensed by the immune system: role of natural killer cell receptors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Natural killer cell-based immunotherapy in cancer: current insights and future prospects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Expansion and activation of natural killer cells for cancer immunotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Replicative potential of human natural killer cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Tracking of [18F]FDG-labeled natural killer cells to HER2/neu-positive tumors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Immunotherapy of malignant brain tumors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Human natural killer cell development and biology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Determinants of antileukemia effects of allogeneic NK cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Selective expansion of human natural killer cells from peripheral blood mononuclear cells by the cell line, HFWT.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

The biology of human natural killer-cell subsets

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Cytosolic delivery of granzyme B by bacterial toxins: evidence that endosomal disruption, in addition to transmembrane pore formation, is an important function of perforin

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4037320

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

31 May 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.174

A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.174

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.174

IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.174

Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.174

Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.174

Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non-relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA-matched sibling donors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.174

Monitoring of a new approach of immunotherapy with allogenic (111)In-labelled NK cells in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.174

CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.11.174

Relevance of KIR gene polymorphisms in bone marrow transplantation outcome

21 January 2018

1 reference

12 December 2020

Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation

1 reference

12 December 2020

Comparative studies of human FcRIII-positive and negative natural killer cells

1 reference

12 December 2020

Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells

1 reference

12 December 2020

Identifiers

DOI

10.2217/IMT.11.174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22329587%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22329587%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PubMed publication ID

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22329587%20AND%20SRC:MED&resulttype=core&format=json